Free Trial

Carisma Therapeutics (CARM) Institutional Ownership

Carisma Therapeutics logo
$0.0001 0.00 (0.00%)
As of 05/15/2026 03:49 PM Eastern

Institutional Ownership Changes (13F Filings) for Carisma Therapeutics (NASDAQ:CARM)

Current
Institutional Ownership
Percentage
44.27%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$59.06K
Number of
Institutional Sellers
(last 12 months)
0
Get CARM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Carisma Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CARM Institutional Buying and Selling by Quarter

Carisma Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/14/2025 Jane Street Group LLC150,810$59K0.0%N/A0.361%
5/6/2025Universal Beteiligungs und Servicegesellschaft mbH200,000$62K0.0%N/A0.479%
2/17/2025Millennium Management LLC120,157$50K0.0%-15.7%0.288%
2/13/2025Renaissance Technologies LLC231,357$97K0.0%+11.9%0.554%
11/19/2024Barclays PLC549,305$539K0.0%+3,661,933.3%1.316%
11/16/2024Geode Capital Management LLC259,184$254K0.0%-8.5%0.621%
11/15/2024Barclays PLC549,305$539K0.0%+3,661,933.3%1.316%
11/15/2024Wexford Capital LP34,861$34K0.0%+75.5%0.083%
9/16/2024Point72 Asia Singapore Pte. Ltd.26,006$40K0.0%N/A0.063%
8/15/2024Point72 Asia Singapore Pte. Ltd.26,006$40K0.0%N/A0.063%
8/15/2024TPG GP A LLC842,031$1.28M0.0%-42.0%2.027%
8/9/2024Renaissance Technologies LLC139,360$212K0.0%-38.3%0.335%
5/10/2024Vanguard Group Inc.1,579,961$3.59M0.0%+0.7%3.803%
5/7/2024Empowered Funds LLC26,984$61K0.0%-43.9%0.065%
2/14/2024Trustees of The University of Pennsylvania1,252,107$3.67M10.3%-28.9%3.102%
10/13/2023SG Americas Securities LLC13,653$58K0.0%N/A0.034%
9/21/2023Barclays PLC5,312$47K0.0%N/A0.013%
8/4/2023American International Group Inc.12,834$113K0.0%N/A0.032%
7/27/2023EA Series Trust40,434$355K0.0%N/A0.100%
6/15/2023Trustees of The University of Pennsylvania2,182,812$6.77M6.6%N/A5.422%
5/15/2023Wittenberg Investment Management Inc.46,703$145K0.1%N/A0.459%
5/12/2023Deuterium Capital Management LLC51,256$159K0.2%N/A0.504%
5/10/2023Connor Clark & Lunn Investment Management Ltd.14,796$46K0.0%N/A0.145%
5/3/2023Jump Financial LLC17,542$54K0.0%N/A0.172%
5/1/2023Virtu Financial LLC15,335$48K0.0%N/A0.151%
4/27/2023Stratos Wealth Partners LTD.19,899$62K0.0%N/A0.195%
4/24/2023Blodgett Wealth Advisors LLC29,660$92K0.1%N/A0.291%
4/14/2023BML Capital Management LLC411,398$1.28M1.1%N/A4.041%


CARM Institutional Ownership - Frequently Asked Questions

During the previous two years, 9 institutional investors and hedge funds held shares of Carisma Therapeutics. The most heavily invested institutionals were TPG GP A LLC ($1.28M), Barclays PLC ($539K), Geode Capital Management LLC ($254K), Renaissance Technologies LLC ($97K), Universal Beteiligungs und Servicegesellschaft mbH ($62K), Jane Street Group LLC ($59K), and Millennium Management LLC ($50K).Learn more on Carisma Therapeutics' institutional investors.

44.27% of Carisma Therapeutics' stock is owned by institutional investors. Learn more on CARM's institutional investor holdings.

The following institutional investors have purchased Carisma Therapeutics' stock in the last 24 months: Barclays PLC ($1.10M), Universal Beteiligungs und Servicegesellschaft mbH ($200K), Jane Street Group LLC ($150.81K), Point72 Asia Singapore Pte. Ltd. ($52.01K), Renaissance Technologies LLC ($24.60K), and Wexford Capital LP ($15K).

Institutional investors have bought a total of 150,810 shares in the last 24 months. This purchase volume represents approximately $59.06K in transactions.



This page (NASDAQ:CARM) was last updated on 5/16/2026 by MarketBeat.com Staff.
From Our Partners